Browse by Track

Type here to filter the list

Tuesday, Jul 23rd
8:00 AM – 10:05 AM CST
Bioanalytical Strategies for New Modalities - Part 1
Location: Salon II
Moderator: Brad Roadcap – Merck & Co., Inc.
Bioanalytical
Tuesday, Jul 23rd
8:05 AM – 8:35 AM CST
Development of siRNA Therapeutics: What Data are Needed for PK and ADA Assessment
Location: Salon II
Speaker: An Zhao, PhD – Regeneron Pharmaceuticals, Inc.
Bioanalytical
Tuesday, Jul 23rd
8:35 AM – 9:05 AM CST
Investigation of Antibody Drug Conjugate’s Fast Clearance: Assay or Biology?
Location: Salon II
Speaker: Cynthia M. Chavez-Eng, PhD – Merck & Co., Inc.
Bioanalytical
Tuesday, Jul 23rd
9:05 AM – 9:35 AM CST
ADCs – LBA vs Hybrid: Hybrid LC-MS/MS Technology vs LBA for the Bioanalysis of Antibody-Drug-Conjugates Examples and Case Studies for Hybrid
Location: Salon II
Speaker: Dawn Dufield, PhD – KCAS Bio
Bioanalytical
Tuesday, Jul 23rd
9:35 AM – 10:05 AM CST
Impact of Soluble Target on Clinical ADA Assessment
Location: Salon II
Speaker: Karen Liao, MD – Merck & Co., Inc.
Bioanalytical
Tuesday, Jul 23rd
10:25 AM – 11:30 AM CST
Bioanalytical Strategies for New Modalities - Part 1 Continued
Location: Salon II
Moderator: Brad Roadcap – Merck & Co., Inc.
Bioanalytical
Tuesday, Jul 23rd
10:25 AM – 10:55 AM CST
Peptide BA Strategies: PK and ADA
Location: Salon II
Speaker: Jo Goodman (she/her/hers) – Celerion
Bioanalytical
Tuesday, Jul 23rd
10:55 AM – 11:25 AM CST
FDA guidance on ADC BA: What to Measure at Different Clinical Stages
Location: Salon II
Speaker: Atiya Taqui (she/her/hers) – Gilead Sciences, Inc.
Bioanalytical
Tuesday, Jul 23rd
11:30 AM – 12:00 PM CST
Advances in Accelerated Quantification of Oligo Therapies with Automated, Microfluidic Methods
Location: Salon II
Partner Presenter: Manny Lozano – Gyros Protein Technologies
Moderator: Brad Roadcap – Merck & Co., Inc.
Bioanalytical
Sponsored By
Tuesday, Jul 23rd
1:30 PM – 3:10 PM CST
Bioanalytical Strategies for New Modalities - Part 2
Location: Salon II
Moderator: Linlin Luo, Dr. (she/her/hers) – Merck & Co., Inc.
Bioanalytical
Tuesday, Jul 23rd
1:35 PM – 2:05 PM CST
Cell-Based Therapies: Adaptations and Considerations for Global Bioanalysis
Location: Salon II
Speaker: Thanh-Long Nguyen, PhD (he/him/his) – ICON plc
Bioanalytical
Tuesday, Jul 23rd
2:05 PM – 2:35 PM CST
Leveraging Learnings from Ligand-Binding and LCMS Methodologies for ARC Bioanalysis
Location: Salon II
Speaker: Catherine L. Brockus, PhD (she/her/hers) – Eli Lilly and Company
Bioanalytical
Tuesday, Jul 23rd
2:35 PM – 3:05 PM CST
Enhancing Cellular Immunogenicity Assessment Through Elispot Testing: Leveraging Advances and Resources
Location: Salon II
Speaker: Sylvia Janetzki, MD (she/her/hers) – ZellNet Consulting, Inc.
Bioanalytical
Tuesday, Jul 23rd
3:30 PM – 4:00 PM CST
Bioanalysis Essentials: Case Studies on mAb Quantification and M10 Validation
Location: Salon II
Partner Presenter: Prajita Pandey, PhD – Emery Pharma
Moderator: Dominic Warrino, PhD – KCAS Bio
Bioanalytical
Sponsored By
Tuesday, Jul 23rd
4:00 PM – 4:45 PM CST
Rapid Fire Presentations: Bioanalytical
Location: Salon II
Rapid Fire Moderator: Dominic Warrino, PhD – KCAS Bio
Bioanalytical
Tuesday, Jul 23rd
4:00 PM – 4:15 PM CST
Hybridization LC-MS for Bioanalysis of Oligonucleotides
Location: Salon II
Rapid Fire Presenter: Brendan Powers, PhD (he/him/his) – LabCorp Drug Development - Bioanalytical Services
Bioanalytical
Tuesday, Jul 23rd
4:15 PM – 4:30 PM CST
Screening Non-Neutralizing Anti-Idiotype Antibodies Against a Drug Candidate for Total Pharmacokinetic and Target Engagement Assay
Location: Salon II
Rapid Fire Presenter: Yong Jiang, PhD (he/him/his) – Johnson & Johnson Innovative Medicine
Bioanalytical
Tuesday, Jul 23rd
4:30 PM – 4:45 PM CST
DMPK of Gefitinib & Gefitinib-3-PROTAC Following Subcutaneous Administration to the Rat Using Micro Sampling and UPLC-MS/MS
Location: Salon II
Rapid Fire Presenter: Andrew Leightner, BS – Waters Corporation
Bioanalytical
Wednesday, Jul 24th
8:00 AM – 10:05 AM CST
Emerging Novel Technologies in the Bioanalytical Field - Part 1
Location: Salon II
Moderator: Lynn Kamen, PhD – BioAgilytix Labs
Bioanalytical
Wednesday, Jul 24th
8:05 AM – 8:35 AM CST
Navigating the Future: AI in Pharma and Regulatory Roadmap
Location: Salon II
Speaker: Stephanie A. Pasas-Farmer, PhD – Ariande Software
Bioanalytical
Wednesday, Jul 24th
8:35 AM – 9:05 AM CST
Microsampling of Liquid Plasma and Dry Milk in Pre-Clinical and Clinical Studies
Location: Salon II
Speaker: Ming Wang, MA (he/him/his) – Merck & Co., Inc.
Bioanalytical
Wednesday, Jul 24th
9:05 AM – 9:35 AM CST
Putting Cell Counting in Context (of use): Analytical Measurements Supporting Cellular Therapies
Location: Salon II
Speaker: Virginia Litwin, PhD (she/her/hers) – Eurofins Clinical Trial Solutions
Bioanalytical
Wednesday, Jul 24th
9:35 AM – 10:05 AM CST
RNASeq: Illuminating Biomarker Landscapes for Precision Medicine - A Comparative Exploration of Multiplex Gene Profiling Technologies
Location: Salon II
Speaker: Kirthi Kutumbaka, PhD (he/him/his) – Eurofins Viracor BioPharma Services
Bioanalytical
Wednesday, Jul 24th
10:25 AM – 11:30 AM CST
Emerging Novel Technologies in the Bioanalytical Field - Part 1 Continued
Location: Salon II
Moderator: Lynn Kamen, PhD – BioAgilytix Labs
Bioanalytical
Wednesday, Jul 24th
10:25 AM – 10:55 AM CST
Single-Cell Proteomics Analysis of Clinical Samples by IsoLight
Location: Salon II
Speaker: Stephen McCarthy – KCAS Bio-Philadelphia
Bioanalytical
Wednesday, Jul 24th
10:55 AM – 11:25 AM CST
Organoids/Organ-On-Chip Models to Assess ADME-Tox at Early Stages of Development
Location: Salon II
Speaker: Rodrigo Cristofoletti, PhD (he/him/his) – University of Florida
Bioanalytical
Wednesday, Jul 24th
11:30 AM – 12:00 PM CST
HRMS as a Tool for Targeted Stabilization and Improved LLOD
Location: Salon II
Partner Presenter: Nicholas Ingram, BS (he/him/his) – Q Squared Solutions
Moderator: Lynn Kamen, PhD – BioAgilytix Labs
Bioanalytical
Sponsored By
Wednesday, Jul 24th
12:00 PM – 12:30 PM CST
Bioanalytical Strategies for Immunogenicity Assessment of ASOs
Location: Salon II
Partner Presenter: Andrea Sequeira – BioAgilytix
Moderator: Lynn Kamen, PhD – BioAgilytix Labs
Bioanalytical
Sponsored By
Wednesday, Jul 24th
1:30 PM – 3:10 PM CST
Emerging Novel Technologies in the Bioanalytical Field - Part 2
Location: Salon II
Moderator: Mark C. Wissel, PhD – Eurofins-Viracor
Bioanalytical
Wednesday, Jul 24th
1:35 PM – 2:05 PM CST
Multiple Automation Approaches for Increased Bioanalytical Laboratory Efficiency
Location: Salon II
Speaker: Enoch Shum, MSCS – Regeneron Pharmaceuticals
Bioanalytical
Wednesday, Jul 24th
2:05 PM – 2:35 PM CST
AAV-Vector Derived Gene Therapy Safety and Efficacy Assays: Platform Selection
Location: Salon II
Speaker: Yanshan Dai, PhD (he/him/his) – Bristol Myers Squibb
Bioanalytical
Wednesday, Jul 24th
2:35 PM – 3:05 PM CST
Validation Best Practices: PCR Case Studies in Shedding
Location: Salon II
Speaker: Bryan M. Gullick, PhD – BioAgilytix Labs, LLC.
Bioanalytical
Wednesday, Jul 24th
3:30 PM – 4:00 PM CST
Rapid Fire Presentations: Bioanalytical
Location: Salon II
Rapid Fire Moderator: Xiuli Li (she/her/hers) – Hikma Pharmaceuticals
Bioanalytical
Wednesday, Jul 24th
3:30 PM – 3:45 PM CST
Identification and Impact Assessment of Matrix Effect for Protein Biomarkers Analyzed by Liquid Chromatography-Mass Spectrometry
Location: Salon II
Rapid Fire Presenter: Mackenzie Bentley, MBA (she/her/hers) – ICON Plc
Bioanalytical
Wednesday, Jul 24th
3:45 PM – 4:00 PM CST
PK Parameters are a Single API Call Away
Location: Salon II
Rapid Fire Presenter: Nathan Teuscher, MS, PhD (he/him/his) – Aplos Analytics, Inc.
Bioanalytical
Thursday, Jul 25th
8:00 AM – 10:40 AM CST
Challenges in Analytical Method Validations and Transfers: Bio and Pharm Joint Session
Location: Salon II
Moderator: Sachin Lohani, Ph.D. – Merck & Co., Inc.
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
8:05 AM – 8:35 AM CST
Strategies for Overcoming Challenges with Bioanalytical Method Transfers
Location: Salon II
Speaker: Amanda L. Hays, PhD – BioAgilytix
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
8:35 AM – 9:05 AM CST
Strategies for the Modernization of Legacy Transfer Methods
Location: Salon II
Speaker: Erik Jerks, B.S. – Eurofins Pharma Bioanalytics Services, LLC
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
9:05 AM – 9:35 AM CST
Risk Assessment for Lab Training and Readiness Prior to Method Transfer
Location: Salon II
Speaker: Joselito Gonzalez, MS Quality Engineering (he/him/his) – Organon
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
9:35 AM – 10:05 AM CST
Lessons Learned from Registrational Analytical Methods Transfer and Validation at External CMOs in Support of Drug Substance Processes
Location: Salon II
Speaker: Peter I. Tattersall, PhD (he/him/his) – Analytical Strategy & Operations / Bristol Myers Squibb
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
10:05 AM – 10:35 AM CST
Joint Session: Panel Discussion
Location: Salon II
Speaker: Amanda L. Hays, PhD – BioAgilytix
Speaker: Erik Jerks, B.S. – Eurofins Pharma Bioanalytics Services, LLC
Speaker: Joselito Gonzalez, MS Quality Engineering (he/him/his) – Organon
Speaker: Peter I. Tattersall, PhD (he/him/his) – Analytical Strategy & Operations / Bristol Myers Squibb
Moderator: Sachin Lohani, Ph.D. – Merck & Co., Inc.
BioanalyticalPharmaceutical Analysis
Thursday, Jul 25th
10:35 AM – 10:40 AM CST
Closing Remarks
Location: Salon II
Moderator: Lynn Kamen, PhD – BioAgilytix Labs
BioanalyticalPharmaceutical Analysis